Tobacco smoking and associated factors among people living with HIV in Uganda by Mdege, Noreen Dadirai et al.
This is a repository copy of Tobacco smoking and associated factors among people living 
with HIV in Uganda.




Mdege, Noreen Dadirai orcid.org/0000-0003-3189-3473, Makumbi, Fredrick, Ssenyonga, 
Ronald et al. (5 more authors) (2021) Tobacco smoking and associated factors among 






This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 




Received August 7, 2020; Editorial Decision December 2, 2020; Accepted December 7, 2020
Advance Access publication December 9, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits 
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
Original Investigation
Tobacco Smoking and Associated Factors 
Among People Living With HIV in Uganda
Noreen Dadirai Mdege PhD1, Fredrick Edward Makumbi PhD2, 
Ronald Ssenyonga MSc2, Frances Thirlway PhD3, Joseph 
K.B. Matovu PhD4,5, Elena Ratschen PhD1, Kamran Siddiqi PhD1,6, , 
Kellen Nyamurungi Namusisi MSc7
1Department of Health Sciences, Faculty of Sciences, University of York, York, UK; 2Department of Epidemiology 
and Biostatistics, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda; 
3Department of Sociology, Faculty of Social Sciences, University of York, York, UK; 4Department of Community & 
Public Health, Faculty of Health Sciences, Busitema University, Mbale, Uganda; 5Department of Disease Control 
and Environmental Health, School of Public Health, College of Health Sciences, Makerere University, Kampala, 
Uganda; 6Hull York Medical School, University of York, Heslington, York, UK; 7Department of Health Policy Planning 
and Management, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda
Corresponding Author: Noreen Dadirai Mdege, PhD, Department of Health Sciences, University of York, Heslington, York 
YO10 5DD, UK. Telephone: 44-1904321836; Fax: 44-1904321383; E-mail: noreen.mdege@york.ac.uk
Abstract
Introduction: The prevalence of smoking among people living with HIV (PLWH) in Uganda is high.
Aims and Methods: We assessed the smoking patterns, behaviors, and associated factors among 
PLWH in Uganda through a cross-sectional survey. Descriptive statistics were used to describe 
smoking patterns and behaviors. Logistic regression was used to identify factors associated with 
current smoking status.
Results: We recruited 777 participants between October and November 2019: 387 (49.8%) cur-
rent smokers and 390 (50.2%) nonsmokers. 60.9% were males, and the mean age was 40.5 (SD 
10.7) years. In multivariate logistic regression, the following increased the odds of being a current 
smoker: being male (odds ratio [OR] 6.60 [95% confidence interval, CI = 4.34–10.04]), having at 
least two smokers among five closest friends (OR 3.97 [95% CI = 2.08–7.59]), living in smoking-
permitted households (OR 5.83 [95% CI = 3.32–10.23]), alcohol use (OR 3.96 [95% CI = 2.34–6.71]), 
a higher perceived stress score (OR 2.23 [95% CI = 1.50–3.34]), and higher health-related quality 
of life (OR 5.25 [95% CI = 1.18–23.35]). Among smokers, the mean Fagerström Test for Nicotine 
Dependence score was 3.0 (SD 1.9), and 52.5% were making plans to quit. Self-efficacy to resist 
smoking and knowledge of the impact of smoking on PLWH’s health were low.
Conclusions: Being male, having at least two smokers among five closest friends, living in 
smoking-permitted households, alcohol use, higher perceived stress scores, and higher health-
related quality of life were associated with being a current smoker. Smokers had low to moderate 
nicotine dependence, high willingness to quit, and low self-efficacy.
Implications: Future behavioral smoking cessation interventions for PLWH should address 
co-consumption with alcohol and comorbid mental health conditions that are common among PLWH 
such as stress. In addition, they should take into account the lack of knowledge among this popula-
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nicotine dependency and high levels of willingness to quit in our sample, smoking cessation interven-
tions, if offered, are likely to support this population in achieving long-term smoking abstinence.
Introduction
With antiretroviral therapy (ART), people living with HIV (PLWH) 
can have a near normal life expectancy.1 However, smoking is a key 
cause of excess morbidity and premature mortality in this popula-
tion.2 Nearly a quarter of deaths among PLWH on ART are attrib-
utable to smoking.3 PLWH, on average, lose 12.3 life-years if they 
smoke: more than twice the number of life-years lost to HIV alone.4 
In Sub-Saharan Africa, the prevalence of smoking among PLWH is 
generally higher than that among HIV-negative individuals5: it is, on 
average, one and a half times higher in men living with HIV than 
HIV-negative men, and almost twofold in women living with HIV 
than HIV-negative women.6 In Uganda, the prevalence of smoking 
among PLWH is 20% for men and 6% for women,7 compared with 
10% and 2% for general population men and women, respectively.8 
Low- and middle-income countries have been recommended to in-
tegrate tobacco use cessation into their HIV programs to address 
comorbidities and improve health outcomes for PLWH.9 However, 
there is a lack of evidence to guide policy and practice on this matter.
Systematic reviews have found that smoking cessation interven-
tions with established effectiveness for the general population are 
also effective among PLWH but only in the short term (<6 months); 
there is a lack of evidence on effective interventions to achieve 
long-term abstinence.10–12 One of the cited reasons for this lack of 
effectiveness is that these interventions do not address the key modi-
fiable smoking determinants, including smoking triggers and relapse 
predictors, common among PLWH who smoke.10,11
Whilst some high-income country studies have characterized 
smoking behaviors among PLWH and factors contributing to the 
high smoking prevalence in this population,13,14 these are not well 
documented in Africa. In this paper, we report the smoking patterns 
and behaviors of PLWH who are in HIV care in Uganda and highlight 
the factors associated with their smoking status. An understanding 
of these smoking determinants will help in designing bespoke behav-




The study was a cross-sectional survey informed by the COM-B 
model which denotes a “behaviour system” in which capability (C), 
opportunity (O), and motivation (M) interact to generate behav-
iour (B).15 The individual’s psychological and physical capabilities 
to engage in the activity concerned, influence their behavior.15 For 
successful long-term quitting, individuals need the relevant know-
ledge and skills. Automatic brain mechanisms and processes that 
energize and direct behavior also influence behavior.15 For example, 
an individual’s perceptions of their susceptibility to the harms of 
smoking16,17 can influence their motivation to quit and smoking be-
havior.17 Other physical or social opportunities that make smoking 
possible or prompt it15 may play a bigger part: eg, the opportunity to 
smoke anywhere, or having many close acquaintances who smoke. 
The COM-B model was used to determine key domains to include in 
the questionnaire (Supplementary Table T1).
Study Sites
We randomly selected eight out of the 15 Uganda Demographic 
Health Surveys (DHS) regions for 2016.18 The smoking preva-
lence across the eight regions (ie, Ankole, Acholi, Bugisu, Busoga, 
Kampala, Lango, South Central, and Tooro) ranged from 3.8% to 
16.7% for men, and 0.3% to 1.1% for women.18 From each of these 
eight regions, we randomly selected one district (Supplementary 
Table T2).18 Thus, eight out of the 112 Uganda DHS districts for 
201618 were included. For each of the eight districts, we used infor-
mation on ART-accredited health facilities from Uganda’s HIV treat-
ment guidelines,19 and information from District Health Officers, to 
select one to three high patient volume HIV clinics from which study 
participants were recruited.
Study Sample
We recruited a convenience sample of PLWH from 16 participating 
HIV clinics between October 1 and November 30, 2019. To be eli-
gible, participants had to be aged ≥18 years, and able to complete 
the survey in local languages or in English. We estimated that we 
would be able to enroll approximately 750 participants (375 cur-
rent smokers and 375 nonsmokers) over the 2 months recruitment 
period. This would allow us enough power to be able to make com-
parisons between the current smokers and nonsmokers, within a 4% 
margin of error with associated 95% confidence levels.20 Sample 
sizes of this magnitude have been found to increase the accuracy of 
estimates and represent the desired parameters in the targeted popu-
lation through simulations, clinical data applications and rule of 
events per variable approaches.21–23
Procedures
Study Approvals
Ethics and other approvals for the study protocol and materials 
were obtained from the Makerere University School of Public Health 
Higher Degrees, Research and Ethics Committee (protocol number 
HDREC704), Uganda National Council for Science and Technology 
(approval number SS5073), and the University of York’s Health 
Sciences Research Governance Committee.
Recruitment and Enrollment
Clinic staff from the participating clinics informed potential par-
ticipants about our study and referred those who were interested 
to research assistants who screened them to determine study eligi-
bility. Those who were eligible were given written study information 
in English, or in a local language. In the case of literacy problems, 
the research assistants also provided the information verbally, in 
the presence of a witness if required. Research assistants obtained 
written informed consent from all study participants.
Measures
We collected sociodemographic data (date of birth, sex, educa-
tion, and marital status) using questions from Uganda’s DHS.18 
Self-reported data on number of years since HIV diagnosis, 
ART status, and number of years on ART were also collected. 
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electricity, flush toilet, latrine, fixed telephone, cell phone, televi-
sion, radio, refrigerator, car or truck, moped/scooter/motorcycle, 
animal drawn cart, boat with motor, boat without a motor, com-
puter, cassette/cd/dvd player)18 from which a wealth index was de-
rived. Asset-based wealth indices are commonly used in low- and 
middle-income countries, although they might not provide a true 
representation of consumption expenditure, particularly where 
only a low proportion of consumption is captured by the included 
assets.24
Current tobacco smoking status was assessed using Global Adult 
Tobacco Survey (GATS) questions.25 A participant was classified as 
a current smoker if they answered “daily” or “less than daily” to 
the question “Do you currently smoke tobacco on a daily basis, less 
than daily, or not at all?” We collected data, from all participants, 
on the following psychosocial and clinical variables that have been 
identified in the literature as potentially contributing to the high 
smoking prevalence and difficulties in quitting among PLWH: al-
cohol consumption using the Alcohol Use Disorders Identification 
Test (AUDIT-C), a three-item alcohol screen26,27; cannabis use using 
the three cannabis use questions from the ASSIST-Lite26,28—cannabis 
is the most widely used and primary illicit psychoactive substance 
of concern in Uganda29; stress using the 14-item Perceived Stress 
Scale13,14,30; depression using the Patient Health Questionnaire-9 
(PHQ-9), a nine-item questionnaire scored from 0 to 27, with a 
higher score indicating more severe depressive symptoms13,14,31; and 
anxiety using the General Anxiety Disorders-7 (GAD-7), a seven-
item instrument scored from 0 to 21, with a higher score indicating 
more severe anxiety.13,14,32 Health-related quality of life (HRQoL) 
was assessed using the EQ-5D-3L which characterizes health on 
five dimensions (mobility, self-care, ability to undertake usual ac-
tivities, pain/discomfort, anxiety/depression).33,34 Smoking restric-
tions at home, number of smokers in the participant’s household, 
and number of close friends who smoke were assessed using GATS 
questions25 and those suggested by Moran et al.35 For smoking re-
strictions at home, participants were stratified into two groups—
those who lived in homes that permitted smoking indoors (ie, 
smoking-permitted homes), and those that did not (ie, smoke-free 
homes). Similarly, participants were stratified into two groups ac-
cording to whether smoking in front of children was permitted or 
not. Details on how these stratifications were achieved are provided 
in Supplementary Material for methods. All study participants com-
pleted GATS questions that assess the use of smokeless tobacco.25
For current smokers, the following information was also 
collected:
 • Types of tobacco product smoked, smoking frequency and quan-
tity, and age on initiation.
 • Nicotine dependency from smoked tobacco using the Fagerström 
Test for Nicotine Dependence (FTND).36
 • Reasons for smoking using the Attitudes Towards Smoking Scale 
(ATS-18)37 and the Risk Perception Scale.38
 • Quit intentions, motivation, and behaviors using questions from 
Fava et al.39 based on the stages of change model. These included 
whether the participant was seriously thinking about quitting or 
planning to quit smoking; and whether they had a quit attempt 
during the 12 months prior to survey completion.
 • For those who had visited a health care provider in the past 
12  months, we assessed whether they were asked about their 
smoking status, advised to quit, or received smoking cessation 
support or referral for such support.
 • Capacity to stop smoking using the Self-Efficacy Questionnaire 
(SEQ-12)40 and the Multidimensional Scale of Perceived Social 
Support.41
 • Whether they mainly smoked alone or with other people.
More detailed descriptions of the AUDIT-C, ASSIST-Lite, EQ-5D-3L, 
Perceived Stress Scale, PHQ-9, GAD-7, FTND, ATS-18, Risk 
Perception Scale, SEQ-12, and Multidimensional Scale of Perceived 
Social Support are provided in Supplementary Material for methods.
Those who were current smokers and had consumed alcohol in 
the past 3 months were also asked about how often they smoked cig-
arettes while drinking alcohol, and what happened to their smoking 
levels when they were drinking.42
The questionnaire was designed to take ~60 minutes to complete.
Data Collection
Data were collected by 14 trained research assistants. A question-
naire was developed, translated to the appropriate non-English lan-
guages and piloted among ~10 participants before being used for 
the survey. The survey was interviewer-administered face-to-face 
using Open Data Kit (ODK) (https://getodk.org/) on mobile phones. 
Missing data and inconsistencies were checked at the end of each 
survey, and before the participant left the interview whenever 
possible.
Participant Reimbursement
Participants did not receive any financial incentives or reimbursement 
but were offered a snack whilst completing the study procedures.
Data Analysis
For the analysis, the districts were grouped into the following geo-
graphical regions: East, North, West, and Central. Principal compo-
nent analysis was used to generate a wealth index for each participant 
by identifying a smaller number of uncorrelated variables from the 
data on ownership of the 15 household assets and using these to 
create a principal component score.43 This score was then used to 
categorize participants into five wealth-quintiles (lowest, lower, 
middle, high, and highest).
For descriptive analysis, variables were summarized and pre-
sented as percentages for categorical variables and means (SDs) or 
medians (interquartile range) for continuous variables.
A multilevel mixed-effects logistic regression model was fitted, 
adjusting for the lowest clustering variable, which was the HIV 
clinic, to identify factors associated with the dependent variable, 
current smoking status (ie, current smoker or nonsmoker). Odds 
ratios (ORs) were used as the measures of association. First, bi-
variate analysis was conducted to determine the empirical relation-
ship between each independent variable and the dependent variable. 
All factors with p < .2 in the bivariate analysis,26 and those that 
were known, theoretically or empirically, to be associated with 
smoking status were included in the multivariate analysis. We tested 
for multicollinearity using the Variance Inflation Factor. The model 
goodness-of-fit was determined using the Hosmer–Lemeshow test, 
while the “best” model from competing models was selected using 
the Akaike’s information criteria.
In the bivariate analysis, the following variables had a p value 
of <.2 and were included in multivariate analysis: sex, number of 
years on ART, number of smokers among five closest friends, living 
in a smoke-free/smoking-permitted household, alcohol consump-
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other psychoactive substances in the past 3 months, perceived stress 
score, and HRQoL (Tables 1–3). Age and level of education were 
also included in the multivariate analysis because of their strong as-
sociation with current smoking status in low- and middle-income 
countries.44
“Years since HIV diagnosis” and “living in a household where 
smoking in front of children is/is not permitted” which had p values 
of <.2 in the bivariate analysis, were not included in the multivariate 
analysis because of high collinearity with “number of years on ART,” 
and “living in a smoke-free/smoking-permitted household,” respect-
ively. “Number of smokers in the household” was also not included 
in the multivariate analysis despite a p value of <.2 because of high 
collinearity with “number of smokers among five closest friends” 
and poor model fit when this variable was included. Statistical sig-




A total of 857 potential participants were screened for study eli-
gibility. Six potential participants did not provide consent, and 74 
were ineligible (40 were waiting their confirmatory HIV test results, 
32 were <18 years of age, and two could not participate for other 
reasons). Seven hundred and seventy-seven (90.7%) were eligible for, 
and consented to participate in, the study (Supplementary Figure F1; 
Supplementary Table T2).
Three hundred and eighty-seven (49.8%) study participants 
were current smokers and 390 (50.2%) were nonsmokers (330 
never smokers and 60 former smokers). 60.9% of the sample 
were male, and the mean age was 40.5 (SD 10.7) years. The 
mean number of years since HIV diagnosis was 7.4 (SD 5.9). 
Seven hundred and seventy-five (99.7%) were receiving ART and 
the mean number of years on ART was 6.4 (SD 5.0). Detailed 
sociodemographic and other participant characteristics are shown 
in Tables 1–3.
Smoking Patterns and Behaviors Among Current 
Smokers
For the 387 current smokers, the mean age of smoking initiation was 
20.4 (SD 6.8) years. 79.6% were daily smokers. The most common 
type of tobacco product smoked was manufactured cigarettes 
(smoked by 76.7% of participants), followed by hand-rolled cigar-
ettes (12.7% of participants) and pipes full of tobacco (7.8%). The 
average number of manufactured cigarettes smoked per smoking 
day was 5.2 (SD 5.6), and this was 3.6 (SD 3.2) for hand-rolled cig-
arettes, and 3.2 (SD 4.1) for pipes full of tobacco (Supplementary 
Table T3).
Nicotine Dependence
The mean FTND score was 3.0 (SD 1.9). Only 1.3% of the smokers 
exhibited signs of high nicotine dependence, whilst 22% were mod-
erately dependent, 27.9% were low to moderately dependent, and 
48.8% had low dependence.
Reasons for Smoking
From the ATS-18, the proportion who agreed/fully agreed that 
smoking is extremely dangerous to their health, or is ruining 
Table 1. General Participant Characteristics
Characteristics Overall (n = 777) Current smokers (n = 387) Nonsmokers (n = 390)
Age in years: mean (SD) 40.5 (10.7) 40.5 (10.3) 40.5 (11.1)
Sex: n (%)†
 Female 304 (39.1) 69 (17.8) 235 (60.3)
 Male 473 (60.9) 318 (82.2) 155 (39.7)
Years since HIV diagnosis: mean (SD)† 7.4 (5.9) 7.0 (5.8) 7.8 (5.9)
Participants on ART: n (%) 775 (99.7) 386 (99.7) 389 (99.7)
Years on ART: mean (SD)† 6.4 (5.0) 6.1 (5.0) 6.7 (5.0)
Marital status: n (%)
 Single/never married 72 (9.3) 38 (9.8) 34 (8.7)
 Married/living with partner 433 (55.7) 214 (55.3) 219 (56.2)
 Ever married (single due to marital disruption) 272 (35.0) 135 (34.9) 137 (35.1)
Region: n (%)
 East 192 (24.7) 95 (24.6) 97 (24.9)
 North 203 (26.1) 98 (25.3) 105 (26.9)
 West 194 (25.0) 96 (24.8) 98 (25.1)
 Central 188 (24.2) 98 (25.3) 90 (23.1)
Education: n (%)
 None 76 (9.8) 31 (8.0) 45 (11.5)
 Primary 434 (55.9) 219 (56.6) 215 (55.1)
 Secondary/tertiary/university/vocational 267 (34.4) 137 (35.4) 130 (33.3)
Wealth index: n (%)
 Lowest 245 (31.5) 132 (34.1) 113 (29.0)
 Lower 141 (18.2) 73 (18.9) 68 (17.4)
 Middle 131 (16.9) 69 (17.8) 62 (15.9)
 High 114 (14.7) 51 (13.2) 63 (16.2)
 Highest 146 (18.8) 62 (16.0) 84 (21.5)
ART = antiretroviral therapy.
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their health, was 91.7% and 84.5%, respectively (Supplementary 
Table T4). 86.3% agreed/fully agreed that smoking leaves an 
unpleasant smell; and this was 80.4% and 70.6% for the state-
ments that smoking gives them bad breath, and that they spend too 
much money on cigarettes, respectively. The majority agreed/fully 
agreed that their cigarette smoke bothers other people a great deal 
(84.3%), their secondhand smoke was dangerous to those around 
them (85.5%), smoking was bad for their skin (56.6%), it bothers 
them to be dependent on cigarettes (62%), and that they would 
have more energy if they did not smoke (65.6%). The majority 
agreed/fully agreed that a cigarette calms them down when stressed 
(72.3%) or when upset (71.6%), and helps them deal with difficult 
situations (62.8%) or concentrate better (61.3%). The majority 
agreed/fully agreed that they like the motions of smoking (54.8%), 
it feels good for them to smoke (64.6%) and they love smoking 
(55%). 42.6% agreed/fully agreed that they like to hold a cigarette 
between their fingers.
Using the Risk Perception Scale, only about 43.6% felt that 
their overall health had been affected by smoking (Supplementary 
Table T5). The majority thought they were likely or very likely 
to develop the following in the future if they continued smoking: 
cancer (71.8%), heart disease (68.5%), and chronic lung disease 
(81.6%). The proportion who thought their overall health was 
worse or much worse than that of the average smoker of their age, 
or the average nonsmoker of their age, was 56.1% and 56.4%, 
respectively.
Social Smoking
One hundred and two (26.4%)  smokers reported mainly being with 
other people when they smoked in the past 30 days, 206 (53.2%) 
smoked mainly when alone, and 79 (20.4%) as often by themselves 
as with others.











 None_minimal 232 (29.9) 106 (27.4) 126 (32.3)
 Mild 206 (26.5) 106 (27.4) 100 (25.6)
 Moderate 167 (21.5) 83 (21.5) 84 (21.5)
 Moderately severe 103 (13.3) 57 (14.7) 46 (11.8)
 Severe 69 (8.9) 35 (9.0) 34 (8.7)
GAD-7: n (%)
 None_minimal 279 (35.9) 128 (33.1) 151 (38.7)
 Mild 246 (31.7) 126 (32.6) 120 (30.8)
 Moderate 136 (17.5) 73 (18.9) 63 (16.2)
 Severe 116 (14.9) 60 (15.5) 56 (14.4)
Perceived Stress 
Score: mean (SD)†








71.74 (19.0) 71.1 (19.1) 72.4 (18.9)
GAD-7  = General Anxiety Disorders-7; PHQ-9  = Patient Health 
Questionnaire-9.
†p < .2 in the bivariate analysis.
Table 2. Use of Tobacco, Alcohol, Cannabis, and Other Psychoactive Substances
Characteristics Overall (n = 777) Current smokers (n = 387) Nonsmokers (n = 390)
Number of smokers in the household: mean (SD)† 0.99 (1.5) 1.6 (1.5) 0.35 (1.1)
Smokers among five closest friends: n (%)†
 0 379 (48.8) 100 (25.8) 279 (71.5)
 1 122 (15.7) 70 (18.1) 52 (13.3)
 2+ 276 (35.5) 217 (56.1) 59 (15.1)
Smoke-free/smoking-permitted home: n (%)†
 Smoke-free home 548 (70.5) 204 (52.7) 344 (88.2)
 Smoking-permitted home 229 (29.5) 183 (47.3) 46 (11.8)
Smoking in front of children permitted: n (%)†
 No 331 (42.6) 111 (28.6) 220 (56.4)
 Yes 446 (57.4) 276 (71.3) 170 (43.6)
Smokeless tobacco use: n (%)
 Not at all 745 (95.9) 369 (95.4) 376 (96.4)
 Daily or less 32 (4.2) 18 (4.7) 14 (3.6)
Alcohol consumption: n (%)†
 No 352 (45.3) 97 (25.1) 255 (65.4)
 Yes 425 (54.7) 290 (74.9) 135 (34.6)
AUDIT-C‡ (>2 female, >3 male)
 Lower risk 151 (35.5) 99 (34.1) 52 (38.5)
 High risk 274 (64.5) 191 (65.9) 83 (61.5)
ASSIST-Lite score (cannabis): n (%)†
 0 736 (94.7) 351 (90.7) 385 (98.7)
 1+ 41 (5.3) 36 (9.3) 5 (1.3)
Use of other psychoactive substances: n (%)†
 No 751 (96.7) 368 (95.1) 383 (98.2)
 Yes 26 (3.4) 19 (4.9) 7 (1.8)
AUDIT-C = Alcohol Use Disorders Identification Test.
†p < .2 in the bivariate analysis.
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Concurrent Alcohol Consumption
Two hundred and ninety smokers were also alcohol consumers: 202 
(69.7%) of these reported that they always or sometimes smoked 
cigarettes whilst drinking alcoholic beverages, and 160 (55.2%) re-
ported that their smoking levels increased when they were drinking 
alcohol. 67.5% expressed mild to extreme difficulty in consuming 
alcohol without smoking a cigarette.
Quit Intentions, Motivation, and Behaviors
One hundred and sixty-one (41.6%)  smokers reported they were 
seriously thinking about quitting in the next 4 weeks, and 125 
(32.3%) in the next 6 months. Two hundred and three (52.5%) were 
planning to quit. Two hundred and twelve (54.8%) indicated they 
had tried to stop smoking in the past 12 months. Of those who had 
tried to stop smoking in the past 12 months, 109 (51.4%) had tried 
to quit without any help during their last quit attempt, 52 (24.5%) 
had tried with assistance from family, 48 (22.6%) had received as-
sistance from their health care provider, and 25 (11.8%) sought as-
sistance from friends. Only 18 (8.5%) had used smoking cessation 
medicines.
Tobacco Use Screening, Advice, and Support From Health Care 
Professionals
Three hundred and forty-three (88.6%)  smokers had visited a 
health care provider in the past 12 months. Of these, 273 (79.6%) 
had been asked if they smoked, and 247 (72.0%) had been given 
advice to stop smoking. Of the ones who had been advised to stop 
smoking, 129 (52.2%) had been offered smoking cessation infor-
mation or support—this is 37.6% of those who had visited a health 
care provider.
Capacity to Stop Smoking
From the SEQ-12, less than 30% of smokers  reported that they 
were absolutely sure they would be able to refrain from smoking 
for each of the following conditions: when feeling nervous, angry, 
depressed, very anxious or when thinking about a difficult problem 
(Supplementary Table T6). The proportion of smokers reporting they 
were absolutely sure they would be able to refrain from smoking 
when they feel the urge to smoke, having a drink with friends, cele-
brating, drinking alcohol, were in the company of other smokers, 
after a meal or having a coffee or tea was between 33% and 41%.
From the Multidimensional Scale of Perceived Social Support, 
significant others were the most common source of support, fol-
lowed by family and then friends (Supplementary Table T7). 65.9% 
strongly/very strongly agreed that there was a special person who 
was around when they were in need. 65.1% strongly/very strongly 
agreed that there was a special person with whom they could share 
their joys and sorrows, whilst this was only 40.6% when asked about 
friends. 58.7% and 63.3% of smokers strongly/very strongly agreed 
that there was a special person who was a source of comfort, and 
cared about their feelings, respectively. 52.7% of smokers strongly/
very strongly agreed that their family really tries to help them, whilst 
this was only 35.1% for friends. 59.7% indicated they could talk 
about their problems with their family, whilst this was 34.6% for 
friends. 52.7% strongly/very strongly agreed that they could get the 
emotional help and support they need from their family, and 49.6% 
strongly/very strongly agreed that their family helps them make de-
cisions. Only 35.9% strongly/very strongly agreed that they could 
count on their friends when things go wrong.
Factors Associated With Current Smoking Status
In the multivariate analysis, males were more likely to be current 
smokers than females (OR 6.60 [95% confidence interval, CI = 
4.34–10.04], p < .001), those with at least two smokers amongst 
their five closest friends were more likely to smoke than those 
without smokers amongst their five closest friends (OR 3.97 [95% 
CI = 2.08–7.59], p < .001), and those living in smoking-permitted 
households were more likely to be current smokers than those living 
in smoke-free homes (OR 5.83 [95% CI = 3.32–10.23], p < .001) 
(Table 4). In addition, those who had drunk alcohol in the past 
3 months were more likely to be current smokers than those who 
had not (OR 3.96 [95% CI = 2.34–6.71], p < .001). A higher per-
ceived stress score (OR 2.23 [95% CI = 1.50–3.34], p <  .001), or 
HRQoL (OR 5.25 [95% CI = 1.18–23.35], p = .030) increased the 
odds of being a current smoker.
Discussion
To the best of our knowledge, this study is the first to generate data 
on the smoking patterns and behaviors, and factors that are asso-
ciated with current smoking status among PLWH who are in HIV 
care in Uganda. Being male, having at least two smokers among five 
closest friends, living in smoking-permitted households and having 
consumed alcohol in the past 3 months were associated with being 
a current smoker. A higher perceived stress score or HRQoL score 
increased the chances of being a current smoker.
In Sub-Saharan Africa, males are generally more likely to be to-
bacco smokers than females, including among PLWH.6,45 However, 
evidence suggests that the prevalence of smoking among Sub-
Saharan African women is rising, with the difference in smoking 
prevalence between boys and girls narrowing.46 Studies have re-
ported that having a social network of smokers, eg, close friends 
who smoke, facilitates smoking and is a barrier to smoking cessa-
tion among PLWH.47 Other studies have also shown that living in 
a smoking-permitted household increases the chances of smoking 
and decreases the chances of smoking cessation.48 Smoking cessa-
tion interventions for PLWH therefore need to consider the social 
and home environments. This might include harnessing the potential 
of significant others and family members as sources of support for 
those making a quit attempt.
As for our study, mental health comorbidities such as stress have 
been reported elsewhere as increasing the chances of smoking among 
PLWH.49 In addition, other studies have also suggested that alcohol 
consumption increases the chances of smoking among PLWH.13,14,26 
Unfortunately, there is a potential for a synergistic negative bio-
chemical interaction between alcohol, tobacco, and the HIV virus 
itself, because of overlapping disease pathways: they all have direct 
toxic effects, and result in chronic inflammation and the suppres-
sion of the body’s immune system.50,51 It is therefore important for 
smoking cessation interventions for PLWH to consider how to deal 
with the high co-consumption of tobacco with alcohol observed in 
this population.
Health problems have been shown to trigger smoking cessa-
tion.52–54 In addition, a near-death experience of full-blown AIDS 
can trigger PLWH to commit to “new life,” 55 and increase their mo-
tivation and intention to quit smoking.56 These factors could explain 
why, for our study, those with a lower HRQoL score where less likely 
to be current smokers than those with a higher score.
Whilst other studies in Sub-Saharan Africa have reported mod-
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smoke,57 for our study, the levels of nicotine dependence were low 
to moderate among current smokers. Motivation and willingness to 
quit smoking were also high in our study population. The Uganda 
Ministry of Health recommends that all PLWH are screened for 
smoking, and those who smoke encouraged to quit,19 and from our 
study, health care professionals seem to be asking about smoking 
and offering cessation advice to PLWH, albeit inconsistently and 
with no cessation support. This could have contributed to the ob-
served high motivation and willingness to quit smoking. HIV treat-
ment initiation in itself can also increase PLWH’s intention to quit 
smoking, particularly during the first 3  months of treatment.7,56 
Thus, ART initiation, and the regular contact that PLWH have with 
health care, provide key opportunities for smoking cessation inter-
ventions. However, self-efficacy to resist smoking was low in this 
population. This is important as the levels of self-efficacy to resist 
smoking predict levels of craving to smoke, quitting and relapse, 
including among PLWH.40,58,59
Our participants are most representative of adults in HIV care; 
thus, our results may only be generalizable to similar populations. 
Additionally, our study did not conduct an analysis for men and 
women separately as the aim was to inform which intervention com-
ponents could be important for PLHW overall. Moreover, previous 
studies in Sub-Saharan Africa did not find major differences between 
men and women,26,60 except for the use of cannabis which was asso-
ciated with smoking only among men.26 Future studies could explore 
differences that might exist in terms of smoking behavior and factors 
associated with smoking between different subgroups of PLWH, par-
ticularly where differentiated care is feasible.
We recruited participants from eight randomly selected regions 
of Uganda to enhance the generalizability of our study findings. In 
addition, unlike other Sub-Saharan African studies that focused on 
comparing smokers to nonsmokers,26,60 we also explored the char-
acteristics of the smokers such as nicotine dependence, reasons for 
smoking, and capacity to stop smoking. We assessed a wider range 
of factors including alcohol consumption and its impact on cigarette 
consumption among smokers, psychosocial factors such as anxiety, 
stress, and depression. This information is vital in informing the de-
velopment of the content of smoking cessation interventions that 
are tailored for PLWH, but is lacking for low- and middle-income 
countries.26
In conclusion, smoking cessation interventions for PLWH should 
address the lack of knowledge among PLWH of the impact of 
smoking on their health in particular, co-consumption with alcohol, 
and low self-efficacy. In addition, they should consider comorbid 
mental health conditions such as stress and the possibility of utilizing 
significant others and family members as sources of support. Given 
the relatively low levels of nicotine dependency and high levels of 
willingness to quit among PLWH who smoke, appropriately tailored 
smoking cessation interventions, if offered, are likely to support this 
population in achieving long-term smoking abstinence.
Supplementary Material
A Contributorship Form detailing each author’s specific involvement with this 
content, as well as any supplementary data, are available online at https://
academic.oup.com/ntr.
Table 4. Multivariate Analysis Results Showing Factors Associated With Being a Current Smoker
Characteristics Unadjusted OR (95% CI) p Adjusted OR (95% CI) p
Age in years 1.00 (0.99, 1.02) .997 1.00 (0.98, 1.02) .954
Sex
 Female 1.00 1.00
 Male 6.99 (4.36, 11.21) <.001 6.60 (4.34, 10.04) <.001
Education
 None 1.00 1.00
 Primary 1.48 (0.90, 2.42) .120 0.69 (0.39, 1.22) .203
 Secondary/tertiary/university/vocational 1.53 (0.45, 3.13) .243 0.58 (0.28, 1.21) .145
Years on ART 0.98 (0.96, 0.99) .036 1.02 (0.98, 1.07) .351
Smokers among five closest friends
 0 1.00 1.00
 1 3.76 (2.72, 5.19) <.001 1.75 (0.92, 3.35) .089
 2+ 10.26 (5.91, 17.83) <.001 3.97 (2.08, 7.59) <.001
Smoke-free/smoking-permitted home
 Smoke-free home 1.00 1.00
 Smoking-permitted home 6.71 (3.80, 11.83) <.001 5.83 (3.32, 10.23) <.001
Current alcohol consumption
 No 1.00 1.00
 Yes 5.65 (3.67, 8.69) <.001 3.96 (2.34, 6.71) <.001
ASSIST-Lite score (cannabis)
 0 1.00 1.00
 1+ 7.9 (2.92, 21.35) <.001 3.84 (0.88, 16.88) .075
Use of other psychoactive substances
 No 1.00 1.00
 Yes 2.82 (1.31, 6.09) .008 1.17 (0.47, 2.96) .735
Perceived Stress Score 1.47 (1.00, 2.15) .051 2.23 (1.50, 3.34) <.001
HRQoL: mean EQ-5D-3L score 2.51 (0.83, 7.54) .102 5.25 (1.18, 23.35) .030
The following variables were not included in the multivariate model despite having a p value <.2 in the bivariate analysis: “Years since HIV diagnosis” because of 
collinearity with “Years on ART”; “Number of smokers in the household” because of collinearity with “smokers among five closest friends” and poor model fit; 
“Smoking in front of children” because of collinearity with “smoke-free/smoking-permitted home.” ART = antiretroviral therapy; CI = confidence interval; HRQoL 
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